000 | 01754 a2200529 4500 | ||
---|---|---|---|
005 | 20250516115016.0 | ||
264 | 0 | _c20130417 | |
008 | 201304s 0 0 eng d | ||
022 | _a1872-8057 | ||
024 | 7 |
_a10.1016/j.mce.2012.10.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCornall, L M | |
245 | 0 | 0 |
_aGPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes. _h[electronic resource] |
260 |
_bMolecular and cellular endocrinology _cJan 2013 |
||
300 |
_a108-18 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcids, Heterocyclic _xpharmacology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aClone Cells |
650 | 0 | 4 |
_aFatty Acids, Nonesterified _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aGenetic Markers |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xdrug effects |
650 | 0 | 4 |
_aObesity, Morbid _xgenetics |
650 | 0 | 4 |
_aOxadiazoles _xpharmacology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xagonists |
700 | 1 | _aMathai, M L | |
700 | 1 | _aHryciw, D H | |
700 | 1 | _aSimcocks, A C | |
700 | 1 | _aO'Brien, P E | |
700 | 1 | _aWentworth, J M | |
700 | 1 | _aMcAinch, A J | |
773 | 0 |
_tMolecular and cellular endocrinology _gvol. 365 _gno. 1 _gp. 108-18 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mce.2012.10.003 _zAvailable from publisher's website |
999 |
_c22186803 _d22186803 |